Preparing For Disaster: Health Readiness Expert’s Performance Review

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Hubwonk Host Joe Selvaggi talks with Emergency Preparedness expert Dr. Paul Biddinger about how experts plan for disasters, and what went right and wrong in this pandemic.

Guest:

Dr. Paul Biddinger holds the MGH Endowed Chair in Emergency Preparedness and is the Director of the Center for Disaster Medicine, and Vice Chairman for Emergency Preparedness in the Department of Emergency Medicine at Mass General. He is also the Director for Emergency Preparedness at Mass General Brigham. Dr. Biddinger additionally serves as the Director of the Emergency Preparedness Research, Evaluation and Practice (EPREP) Program at the Harvard T. H. Chan School of Public Health, and holds appointments at Harvard Medical School and at the Chan School. Dr. Biddinger serves as a special advisor to the Massachusetts Medical Society’s Committee on Preparedness and serves as a medical officer for the MA-1 Disaster Medical Assistance Team (DMAT) in the National Disaster Medical System (NDMS) in the US Department of Health and Human Services (HHS).

Dr. Biddinger is an active researcher in the field of emergency preparedness and has lectured nationally and internationally on topics of preparedness and disaster medicine. He has authored numerous articles and book chapters on multiple topics related to emergency medical services and disaster medicine. He has also responded to numerous prior incidents, including Hurricane Katrina, the Boston Marathon bombings, Superstorm Sandy, the 2015 Nepal earthquakes and others. He completed his undergraduate study in international relations at Princeton University, attended medical school at Vanderbilt University, and completed residency training in emergency medicine at Harvard.

Get new episodes of Hubwonk in your inbox!

Recent Episodes of Hubwonk

Rent Control Re-Explored: What the Past Can Teach the Future

Hubwonk Host Joe Selvaggi talks with economist and MIT Professor Chris Palmer about his research and analysis of the effects of rent control in Cambridge during its 25-year implementation and in the aftermath of its repeal.

Defusing Ideological Tribalism: Methods for Communicating Across Political Language Barriers

Hubwonk host Joe Selvaggi talks with economist and author Dr. Arnold Kling about his book, The Three Languages of Politics, Talking Across the Political Divides, which outlines the dynamics of political tribalism, defines the respective world view and vocabulary of progressives, conservatives, and libertarianism, and offers methods for communicating and persuading across ideological lines in a way that fosters civil, productive, public debate.

Marathon Endurance Test: Leaders Pave the Way for Boston’s Return

Hubwonk host Joe Selvaggi talks with Boston Athletic Association’s CEO Tom Grilk about the leadership challenges of cancelling the world’s oldest continuous marathon, a $200-million benefit to the region involving eight municipalities and 10,000 volunteers, in the face of a pandemic - and how cooperation among stakeholders brought back the epic event to be run this October.

Economic Long Covid: Mixed Health Messages for Baystate Businesses

Hubwonk host Joe Selvaggi talks with NFIB’s Chris Carlozzi and Retailers Association of Massachusetts' Jon Hurst about the challenges and future prospects for businesses as they adapt to widespread consumer confusion caused by vague and often conflicting public health messaging from our political leadership.

Enduring the Maelstrom: Lessons from MassPort Leadership During 9/11

Hubwonk host Joe Selvaggi talks with author and former MassPort CEO Virginia Buckingham about her recently released book, On My Watch: A Memoir, which chronicles her experience leading the organization through 9/11 and the life and leadership lessons learned from that tragic day.

Rescuing Afghan Refugees: Finding Redemption amidst the Wreckage of Collapse

Hubwonk host Joe Selvaggi talks with Jeffrey Thielman, President and CEO of the International Institute of New England, about the path refugees must take to resettle in the US, how organizations like his facilitate and integrate refugees including those recently displaced in Afghanistan, and what individuals concerned about the fate of refugees can do to support their resettlement. 

Untangling Variants & Outbreaks: Can Vaccines & Natural Immunity Outrun Delta?

Hubwonk host Joe Selvaggi talks with author, surgeon, and public health expert Dr. Marty Makary about the COVID-19 Delta Variant, the durability of natural and vaccinated immunity, the benefits of booster shots, and the health risks for children as we move into the fall.

Targeting Pharma: Infrastructure Bill Employs Price Controls To Offset Unprecedented Price Tag

Hubwonk host Joe Selvaggi talks with Pioneer Institute Visiting Fellow in Life Sciences Dr. William Smith about how the price control features of the emerging $3.5 trillion infrastructure bill might affect the pharmaceutical Industry, both nationwide and here in Massachusetts, and what effect that change will have on drug consumers.

Examining Eviction Moratoriums: Testing Constitutional Limits of Executive Branch Power

Hubwonk host Joe Selvaggi talks with constitutional scholar and George Mason Law Professor Ilya Somin about the flaws and legal vulnerabilities of the first and second CDC eviction moratoriums and discuss what current and future court rulings will mean for the limits of executive agency powers.

Pandemic Pension Payout: Essential COVID-19 Public Workers Rewarded Whether Essential or Working

Hubwonk host Joe Selvaggi talks with Pioneer Institute’s Director of Research and former Massachusetts Inspector General and State Representative Greg Sullivan about HB 2808, COVID-19 Essential Employee Retirement Credit Bonus, discussing the merits of the recently proposed joint bill, its cost, and our current public debt burden in the Commonwealth.

College Debt Explained: Education Pays When Students Choose Wisely

Hubwonk host Joe Selvaggi talks with American Enterprise Institute resident fellow and education economist Beth Akers about the American student debt crisis (totalling $1.6 trillion). They explore who borrows, who is in debt, and which policy choices might best serve the financial needs of every student. 

Chasing Election Integrity: Strict Voter ID Laws’ Impact on Turnout and Fraud

Joe Selvaggi talks with Harvard Business School Professor Vincent Pons about his recently released NBER paper on the effects of strict voter ID laws on voter behavior and fraud across the United States over 10 years, examining the results of the 1.6 billion observation dataset by age, race, gender, and party affiliation.

The Oldest Hatred: Calling Out Antisemitism In Its Many Forms

Hubwonk host Joe Selvaggi talks with Boston Globe opinion writer Jeff Jacoby about the troubling increase in antisemitic incidents, including the recent attack on a Boston rabbi, and how our current political rancor fans the flames of bigotry nationwide.

Court Preserves Privacy: First Amendment Ruling Defends Non-Profits From Modern-Day McCarthyism

Hubwonk Host Joe Selvaggi talks with CATO research fellow and constitutional scholar Trevor Burrus about the recent Supreme Court ruling, Americans For Prosperity Foundation v. Bonta, reaffirming the right to privacy by denying the state of California the right to compel non-profits to disclose their list of donors.

Renters’ Unsung Heroes: Small Landlords Endure Without Income or Relief

Hubwonk host Joe Selvaggi talks with MassLandlords’ Doug Quattrochi about ways landlords faced the challenges of being caught between tenants unable to pay rent during COVID-19 shutdown and having little or no programmatic relief from state and federal agencies.

Alzheimer Breakthrough Disillusionment: Confusion on FDA’s Approval of Expensive and Possibly Ineffective Drug

Hubwonk host Joe Selvaggi talks with precision medicine expert Hannah Mamuszka and Pioneer Institute's Bill Smith about the promises and pitfalls of the newly approved Alzheimer’s drug Aduhelm, and the challenges presented when new, expensive drugs of dubious benefit are introduced to the nation’s formulary.